Daniel Stover, MDThe James Cancer Center
- Breast Cancer
- Medical Oncology
I am a medical oncologist specializing in the treatment of breast cancer and a scientist focusing on improving the understanding and treatment of breast cancer. I attended medical school and completed my residency at the Vanderbilt University School of Medicine. I completed my medical oncology and research fellowships at the Dana-Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts. In addition to my work at the OSUCCC – James, I also serve as an assistant professor in Internal Medicine at The Ohio State University.
My research focuses on integrating tumor genomic profiling with patient characteristics and outcomes with a goal to develop new treatments for breast cancer. My work has been published in numerous journals, including Nature, Cell, Nature Medicine, Journal of Clinical Oncology, and Clinical Cancer Research among others.
My first exposure to oncology occurred as a high schooler in a cancer research lab at the OSUCCC – James. In 2017, I returned to The James as a faculty member after 18 years of diverse training across the country. At The James, our dedication to patient care is unmatched, and I’m honored to be part of a center that looks at every aspect of a patient’s treatment, from diagnosis to management. I’m confident our work, research and collaboration will move us closer to a cancer-free world.
Education and Background
Vanderbilt University School of Medicine
Dana Farber Cancer Institute
- American Board of Internal Medicine
- American Board of Internal Medicine (Subspecialty: Medicine Oncology)
- Department of Internal Medicine
- Division of Medical Oncology
I see patients at
Stefanie Spielman Comprehensive Breast Center
1145 Olentangy River Road, Columbus, Ohio 43212
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Stover has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.